CALMA B — Calmark Sweden AB Share News
0.000.00%
- SEK11.35m
- SEK9.07m
- SEK0.14m
Brief: Calmark Comments On The Effects From COVID-19
Brief: Calmark Sweden Q4 Operating Loss Widens To SEK 2.3 Million
Brief: Calmark Sweden Signs Distributor Agreement With Triolab
Brief: Calmark: CE Conformity Markings For Neo-Glucose, Neo-LDH Delayed
Brief: Calmark: Neo-Bilirubin To Obtain CE Mark Approval In January 2020
Brief: Calmark Sweden: Creades Becomes Third Largest Owner In Co
Brief: Calmark Sweden: Rights Issue Massively Oversubscribed
Brief: Calmark Sweden Q3 Operating Loss Widens To SEK 1.5 Mln
Brief: Calmark Sweden: Products For Biomarkers, LDH And Glucose Will Not Obtain CE Conformity Markings Until Q1 2020
Brief: Calmark Announces Rights Issue Of SEK 24.3 Mln
Brief: Calmark Sweden Starts Negotiations With Triolab
Brief: Calmark Sweden And Nublis Terminate Agreement In Advance
Brief: Calmark Sweden AB Gets Patent In Sweden